Microbix Biosystems Inc.
MBX.TOTSXHealthcare● Active
$0.28
+$0.01(+3.70%)
Market Cap$38794840
P/E Ratio—
52W High$0.34
52W Low$0.21
Microbix Biosystems Inc. (MBX.TO) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MBX.TO · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($2.25M) | $3.52M | ($0.04M) | $1.79M | $3.23M |
| Depreciation & Amort. | $1.78M | $1.61M | $1.16M | $1.04M | $0.82M |
| Stock-Based Comp. | $0.00M | $0.71M | $0.74M | $0.65M | $0.38M |
| Change in Working Capital | ($0.76M) | ($1.77M) | ($0.22M) | ($0.34M) | ($3.22M) |
| Net Cash from Operations | ($0.08M) | $4.35M | ($1.09M) | $3.47M | $2.11M |
| Investing Activities | |||||
| Capital Expenditure | ($0.80M) | ($1.91M) | ($1.02M) | ($2.03M) | ($1.30M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.80M) | ($1.91M) | ($1.02M) | ($2.03M) | ($0.62M) |
| Financing Activities | |||||
| Common Stock Repurchased | ($1.73M) | ($0.93M) | ($1.12M) | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.85M) | ($0.52M) | $1.24M | ($1.38M) | $0.08M |
| Net Cash from Financing | $0.03M | ($1.08M) | $0.23M | $2.06M | $8.41M |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.88M) | $2.44M | ($2.11M) | $1.44M | $0.80M |
| FCF Margin %(computed) | -4.72% | 9.61% | -12.78% | 7.55% | 4.33% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · M
Explore more Microbix Biosystems Inc. data
About Microbix Biosystems Inc. (MBX.TO) Cash Flow Statement
Microbix Biosystems Inc. generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2025 — a FCF margin of -4.72%. Capital expenditure was ($0.00B).
Frequently asked questions
MBX.TO · 4 questionsMicrobix Biosystems Inc. generated free cash flow of ($0.00B) for 2025, down 136.0% year-over-year.
MBX.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10